Behcet’s disease falls under the umbrella of autoimmune diseases and disorders.
It affects approximately 400 of 100,000 people in Turkey, and is also commonly found in the Middle East. It has a higher prevalence in East Asia and countries in the eastern Mediterranean countries.
In the United States, only 1 out of every 170,000 people is affected. The onset of Behcet’s usually manifests during the individual’s 20s and 30s, but it can occur in anyone regardless of gender, race, or age, although women are more likely to be affected.
It’s unknown what causes Behcet’s disease, although studies are pointing to environmental, viral, and bacterial origins. Symptoms include ulcers on mucous membrane laden areas such as the mouth and genitals. Some people report developing arthritis and skin lesions as a result of Behcet’s. Others suffer from inflammation in various parts of their body, such as their eyes, central nervous system, and digestive tract.
It’s important to note that Behcet’s disease is not contagious.
Treatment is generally concentrated on relieving symptoms, because to date, there is no specific treatment for the disease, nor is there a cure.
If you would like to gain a deeper understanding of Behcet’s disease, plan on attending the 2017 International Vasculitis Symposium which will be held in Chicago, Illinois, on June 23 – 25, 2017 at the Chicago Marriot O’Hare. To register, click here. Pre-registration ends June 17, 2017. To learn more, contact the Vasculitis Foundation.
The following video will introduce you to some of the speakers, and an idea of what topics will be covered. Enjoy!